A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors
Seagen Inc.
Seagen Inc.
Novartis
Var2 Pharmaceuticals
Massive Bio, Inc.
A2 Biotherapeutics Inc.
Guardant Health, Inc.
ModeX Therapeutics, An OPKO Health Company
Tempus AI
Corvus Pharmaceuticals, Inc.
Klus Pharma Inc.
MacroGenics
SpeciCare
Novartis
INSYS Therapeutics Inc